Abstract Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time,
exerting a significant impact on physical and mental health and leading to death. The …

Nanomedicine is currently focused on the design and development of nanocarriers that
enhance drug delivery to the brain to address unmet clinical needs for treating …

Chronic inflammation contributes to the pathogenesis of many diseases, including
apparently unrelated conditions such as metabolic disorders, cardiovascular diseases …

Degenerative diseases affecting bone tissues and the brain represent important problems
with high socio-economic impact. Certain bone diseases, such as osteoporosis, are …

Abstract Alzheimer's disease (AD), a multi-factorial neurodegenerative disorder has affected
over 30 million individuals globally and these numbers are expected to increase in the …

Today, it is well known that radioactive nano systems, particularly radioactive nano particles
(NPs) based on polymeric NPs possess great advantages on nuclear imaging and/or …

The science of drug delivery has witnessed remarkable advancements in the everevolving
era of pharmaceuticals and healthcare that promise to revolutionize clinical therapeutics …

Neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, glioma,
depression, and anxiety are seriously affecting humans across the globe. Currently, FDA …

The pharmacokinetics of nanocarriers and novel drug delivery systems play a pivotal role in
optimizing the delivery and therapeutic efficacy of drugs. These systems, such as liposomes …